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The innate immune system recognizes pathogen-associated molecular patterns (PAMPs) through pattern
recognition receptors (PRR) and transduces downstream signaling to activate the host defense. Here we report
that in addition to direct PAMP-PRR interactions, live Candida albicans cells can release soluble factors to
actively potentiate interleukin-6 (IL-6) and IL-8 production induced in human mononuclear cells by the fungi.
Although protease-activated receptor 1 (PAR1) and PAR2 ligation can moderately upregulate Toll-like recep-
tor 4 (TLR4)-mediated IL-8 production, no effect on the C. albicans-induced cytokine was apparent. Similarly,
the blockade of PAR signaling did not reverse the potentiation of cytokine production induced by soluble
factors released by C. albicans. In conclusion, C. albicans releases soluble factors that potentiate cytokine
release in a PAR1/2-independent manner. Thus, human PAR1 and PAR2 have a redundant role in the
activation of human cells by C. albicans.
Candida albicans is a commensal fungal microorganism col-
onizing the skin and/or mucosa of healthy individuals. Al-
though C. albicans colonization is usually asymptomatic, for
certain categories of patients, C. albicans can cause a wide
range of clinical syndromes, from oral thrush and vaginal can-
didiasis to systemic candidiasis. Severe C. albicans infection
can cause high rates of mortality for immunocompromised
patients, such as HIV and intensive care unit (ICU) patients.
Host innate immunity plays a major role in the elimination of
C. albicans infection. The first-line host defense is the physical
barrier represented by the intact skin and mucosal surface,
while the direct elimination of the fungus is executed mainly by
polymorphonuclear leukocyte (PMN). A breakdown in muco-
sal barrier defense and decreased PMN function provides a
chance for C. albicans invasion of tissues. However, to activate
the host defense mechanisms, leukocytes must possess the abil-
ity to discriminate self and nonself. Host innate cells are
equipped with a limited panel of germ line-encoded pattern
recognition receptors (PRRs), which can recognize structures
of microorganism called pathogen-associated molecular pat-
terns (PAMPs). The main PRRs for C. albicans are the Toll-
like receptors (TLRs) and the C-type lectin receptors (CLRs).
In this respect, C. albicans N-linked mannan is recognized by
mannose receptor (MR), and O-linked mannan is recognized
by TLR4, while -glucan is recognized by dectin-1 in cooper-
ation with TLR2 (15). It was demonstrated that through the
direct interaction between C. albicans PAMPs and host PRRs,
downstream cytokines are released, recruiting more effector
cells and inducing inflammation to control fungal outgrowth.
However, besides PAMPs from cell wall components, C. albi-
cans also releases soluble factors into the surrounding environ-
ment, including metabolites, shedding PAMPs and extracellular
hydrolases. Among them, the most well-studied factors are the
secreted aspartic proteases (Saps). So far, 10 Sap isoenzymes
encoded by the genes SAP1 to SAP10 have been identified for C.
albicans (12, 13). It was previously reported that Saps have a
variety of functions in C. albicans infection and are involved in
phenotype switching, biofilm formation, nutrient acquisition, and
tissue invasion/damage, etc. (12), and Saps have been proven to
be important virulence factors. Using the reconstituted human
vaginal epithelium (RHVE) model, it was previously shown that
the addition of the aspartic protease inhibitor pepstatin A that
neutralizes Saps strongly reduced the level of cytokine production
induced by C. albicans infection (19). In in vitro models of oral
(18) and cutaneous (2) candidosis, the presence of pepstatin A
reduced the virulence of C. albicans.
Protease-activated receptors (PARs) are seven-transmem-
brane G-protein-coupled receptors with a N-terminal extracel-
lular peptide (9). After the cleavage of the N-terminal end by
a protease, a tethered ligand will be exposed, and this will bind
intramolecularly to its ligand binding site and activate down-
stream signaling. Both host-derived proteases (e.g., PR3) (20)
released in response to infection and pathogen-derived pro-
teases (e.g., gingipains from Porphyromonas gingivalis) (21) are
able to cleave PARs, thus activating downstream proinflam-
matory cytokine production and secretion.
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A recent study suggested a role of PARs in fungal recogni-
tion in mice (11). Moretti et al. also reported cross talk inter-
actions between PARs and TLRs in inflammation against fun-
gal infection. It was previously proposed that the inflammation
in response to C. albicans is promoted by PAR1 and PAR2
activation, which is downstream of the TLR2 signaling pathway
(11). However, nothing is known regarding the potential role
of PARs in the recognition of C. albicans by human cells. In
this study we investigated the potential role of soluble factors
released by live C. albicans cells in the induction of cytokine
production in human leukocytes, and we examined the role
played by PAR1 and PAR2 in mediating these effects.
MATERIALS AND METHODS
Volunteers. Blood samples were collected from healthy, nonsmoking volun-
teers. After written informed consent was obtained, venipuncture was performed
to collect blood into 10-ml EDTA tubes (Monoject).
Reagents. Lipopolysaccharide (LPS) (Escherichia coli serotype O55:B5) was
purchased from Sigma. LPS was repurified as described elsewhere previously (7).
Synthetic Pam3Cys was purchased from EMC Microcollections, and the produc-
tion of highly purified particulate -glucan and soluble -glucan (glucan phos-
phate) was described elsewhere previously (22).
C. albicans strains and conditioned medium. C. albicans ATCC MYA-3573
(UC 820) (10) was used as the wild type. sap1-3 (8), sap4-6 (17), and sap9-10
(1) C. albicans strains were used and are well characterized in the literature. C.
albicans organisms were grown overnight in Sabouraud broth at 37°C, and cells
were thereafter harvested by centrifugation, washed twice, and resuspended in
culture medium (RPMI 1640 medium; ICN Biomedicals) (23). For the prepa-
ration of heat-killed C. albicans cells, live C. albicans cells were harvested, heated
for 1 h at 100°C, and resuspended in culture medium at a final concentration of
106 C. albicans yeast cells/ml. For the preparation of conditioned medium, live C.
albicans cells were inoculated into RPMI medium at a concentration of 106 C.
albicans yeast cells/ml and grown in an incubator at 37°C for 24 h. Conditioned
medium was collected by centrifugation, and the supernatant was filtered
through a 0.22-m filter and stored at 20°C before use. The pH of conditioned
medium was 6.9. The protease activity of the conditioned medium was deter-
mined by use of a QuantiCleave protease assay kit (Pierce), and no difference in
protease activity was found between fresh harvested (36.5 ng/ml) and fresh
thawed (35.9 ng/ml) conditioned media.
Fractionation of conditioned medium. C. albicans conditioned media were fraction-
ized by centrifugal filter units (Millipore) with different molecular mass cutoffs (3-, 30-,
and 100-kDa cutoffs) according to the manufacturer’s protocol. After centrifugation, the
concentrated protein fractions were reconstituted back to the original volume.
Isolation and stimulation of PBMCs. The separation and stimulation of pe-
ripheral blood mononuclear cells (PBMCs) were performed as described else-
where previously (15). Cells were adjusted to 5  106 cells/ml and thereafter
incubated at 37°C in round-bottom 96-well plates (volume, 100 l/well) with
either heat-killed C. albicans microorganisms (106 microorganisms/ml) or culture
medium, with or without C. albicans conditioned medium (50 l/well), and the
final volume of each well was 200 l. After 24 h, supernatants were collected and
stored at 20°C until assayed. For the cross talk experiments between PARs and
PRRs, PBMCs were stimulated simultaneously with PRR ligands, LPS (1, 10,
and 100 ng/ml), Pam3Cys (0.1, 1, and 10 g/ml), or -glucan (1, 10, and 100
g/ml), and 100 M of PAR-1 agonist peptide or PAR2 agonist peptide. After
24 h, supernatants were collected and stored at 20°C until assayed.
Transwell stimulation experiments. Live C. albicans cells (106 microorganisms/
ml) were cultured in the upper well of a 24-well transwell system (pore size, 0.4 m;
Corning) to avoid direct contact between live C. albicans cells and PBMCs but
allowing the free diffusion of the released soluble factors. PBMCs and other stim-
ulants were cultured in the lower well. The culture supernatant was collected after
removing the upper well and stored at 20°C before cytokine measurements.
PAR agonist and antagonist peptides. PAR1 agonist peptide TFLLR and
PAR2 agonist peptide SLIGKV were synthesized by Ansynth Service B.V., the
Netherlands. PAR1 antagonist peptide FLLRN and PAR2 antagonist peptide
FSLLRY were purchased from Peptides International. To determine the role of
PARs in our system, both agonist peptides and antagonist peptides were added
simultaneously with heat-killed C. albicans cells at a concentration of 100 M.
Cytokine measurements. Interleukin-6 (IL-6) and IL-8 concentrations were mea-
sured by use of commercial sandwich enzyme-linked immunosorbent assay (ELISA)
kits (Pelikine Compact; CLB, Amsterdam, the Netherlands) according to the man-
ufacturer’s instructions. Measurements of human tumor necrosis factor alpha
(TNF-) were determined by specific ELISA as described elsewhere previously (6).
Quantitative PCR. PBMCs were stimulated as described above. After 24 h, the
supernatant was removed, and the cells were resuspended in 200 l of RNAzol
B RNA isolation solvent (Campro Scientific) and stored at 80°C. mRNA was
isolated according to the instructions of manufacturer. cDNA was synthesized
from 1 g of total RNA by use of Superscript reverse transcriptase (Invitrogen).
Relative mRNA levels were determined by using the Bio-Rad i-Cycler and the
SYBR green method (Invitrogen). The following primers were used: PAR1
forward primer 5-CAAATGCCACCTTAGATCCCC-3 and reverse primer 5-
CTTCTGAGATGAATGCAGGAAGT-3, PAR2 forward primer 5-CTGGTT
CCCCTTGAAGATTGC-3 and reverse primer 5-TCACGATGACCCAATAC
CTCT-3, and 2 M forward primer 5-ATGAGTATGCCTGCCGTGTG-3 and
reverse primer 5-CCAAATGCGGCATCTTCAAAC-3 (Biolegio). Values are
expressed as fold increases in mRNA levels relative to those for unstimulated cells.
Statistical analysis. Results from at least 3 sets of experiments were pooled
and analyzed by using SPSS 16.0 statistical software. Data are given as means 
standard errors (SE), and the Wilcoxon signed-rank test was used to compare
differences between groups (unless otherwise stated). The level of significance
was set at a P value of 	0.05.
RESULTS
C. albicans-released components modulate cytokine produc-
tion. For the purpose of studying the role of the C. albicans-
released components in modulating cytokine production, fresh
isolated human PBMCs were cultured in the presence or ab-
sence of C. albicans conditioned medium. No significant pro-
duction of TNF, IL-6, or IL-8 was induced by the conditioned
medium alone (Fig. 1A). C. albicans conditioned medium in-
duced a minor increase in IL-8 release, but this was not sta-
tistically significant.
To test whether conditioned medium can modulate cytokine
release induced by PRR triggering, human PBMCs were stim-
ulated with heat-killed C. albicans cells in the presence or
absence of C. albicans conditioned medium. The results show
that conditioned medium of C. albicans potentiates PBMC
IL-6 and IL-8 secretion in response to heat-killed C. albicans
stimulation (Fig. 1B). The role of the components released by
C. albicans in cytokine production was also investigated in a
transwell system to separate the direct contact between live C.
albicans cells and PBMCs. Live C. albicans cells growing in the
upper compartment released components that augmented IL-6
and IL-8 production induced by heat-killed C. albicans cells
(Fig. 1C). In addition, IL-10 production was also enhanced,
while interferon (IFN) release was in turn downregulated by
the conditioned medium (data not shown). Taken together, the
results from conditioned medium and transwell experiments
demonstrated a modulatory effect of C. albicans-released sol-
uble factors on the cytokine response of PBMCs. This was not
due to differences between the pHs of RPMI medium (pH 7.0)
and conditioned medium (pH 6.9).
C. albicans conditioned medium has no effect on par1 and
par2 expression. The enzymatic activation of PAR1 and PAR2
was recently reported to play a role in inflammation and im-
munity in response to fungal infection in a murine model (11),
and we hypothesized that they may play a role in cytokine
modulation by C. albicans-released proteases. The incubation
of human PBMCs with C. albicans conditioned medium did
not influence par1 and par2 mRNA expression compared to an
RPMI medium control group (Fig. 2), indicating that C. albi-
cans-released soluble factors do not modulate par1 and par2
gene expression at the transcriptional level.
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PAR1 and PAR2 agonists slightly modulate IL-8 production
in combination with LPS through TLR4. TLR2, TLR4, and
dectin-1 were identified to be the major PRRs for C. albicans
recognition (14), and it was previously reported that inflam-
mation induced by C. albicans through TLR2 might be poten-
tiated by PAR1 and PAR2 signaling in mice (11). Human
PBMCs were stimulated with agonist peptides of PARs,
PAR1-AP (TFLLR) and PAR2-AP (SLIGKV), together with
FIG. 1. Candida culture conditioned medium modulates host cytokine production. (A) Human PBMCs were incubated with RPMI or C.
albicans culture conditioned medium. The supernatant was collected for TNF, IL-6, and IL-8 ELISA measurements after 24 h of stimulation.
(B) Human PBMCs were stimulated with heat-killed (H.K.) C. albicans in the presence of RPMI or C. albicans conditioned medium. Supernatants
were collected for TNF, IL-6, and IL-8 measurements after 24 h of stimulation. (C) Human PBMCs were seeded in the lower well of transwell
plates and stimulated with heat-killed C. albicans cells, while RPMI medium or live C. albicans cells were added to the upper well. Supernatants
were collected for TNF, IL-6, and IL-8 measurements after 24 h of stimulation. The data are cumulative results of three duplicate data from 6
different donors and are expressed as means  SE (, P 	 0.05 compared to PBMCs incubated with heat-killed Candida alone).
FIG. 2. Modulation of par1 and par2 mRNA expression by C. albicans culture conditioned medium. Human PBMCs were incubated with RPMI
medium, C. albicans conditioned medium, and heat-killed C. albicans cells. (A and B) par1 (A) and par2 (B) mRNA expression levels were
determined by real-time PCR, normalized to the expression of the RPMI medium-incubated group.
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LPS (Fig. 3A), Pam3Cys (Fig. 3B), or -glucan (Fig. 3C), to
assess the cross talk between PARs and TLR2/TLR4/dectin-1.
A slight potentiation of IL-8 production when cells were stim-
ulated with TLR4 and PAR1 ligands (23% increase) and TLR4
and PAR2 (40% increase) was observed. However, neither
PAR1 nor PAR2 augmented TNF and IL-6 production in
combination with all three PRR agonists used in this study.
PAR1 and PAR2 agonists and antagonists had no effect on
modulating C. albicans-induced cytokine production. To fur-
ther assess the role of PAR1 and PAR2 in modulating cytokine
production during C. albicans infection, heat-killed C. albicans
was used as the source of fungal PAMPs, while PAR1-AP
(TFLLR) and PAR2-AP (SLIGKV) were used to activate
PAR signaling, mimicking the possible role of C. albicans-
released soluble factors. However, either individual PAR ago-
nists or PAR agonists in combination failed to potentiate heat-
killed C. albicans-induced IL-6 and IL-8 production in human
PBMCs (see Fig. S1 in the supplemental material).
Since PAR1 and PAR2 agonists could not modulate the
cytokine profiles induced by heat-killed C. albicans, PAR1 and
PAR2 antagonists were used to study the role of PAR1 and PAR2 in
live C. albicans-induced cytokine upregulation. PAR1-ANT
(FLLRN) and PAR2-ANT (FSLLRY) were used to block
PAR1 and PAR2 signaling in the transwell system. As ex-
pected, both PAR1-ANT and PAR2-ANT could not block the
IL-6 and IL-8 upregulation induced by live C. albicans-released
soluble factors either respectively or in combination (data not
shown). The lack of an effect of PAR stimulation on the block-
ade of cytokine production was also apparent when a different
strain of C. albicans (NGY 152) was used or when cells were
stimulated with Candida dubliniensis or Candida glabrata (see
Fig. S2 in the supplemental material).
Secreted soluble factors, but not distinct Saps, modulate C.
albicans-induced cytokine production. Saps are considered to
be important virulence factors for C. albicans, and they are
secreted into the extracellular space from C. albicans cultures.
To investigate the role of Saps in host cytokine modulation, we
harvested C. albicans conditioned media from different sap
mutant C. albicans strains (sap1-3, sap4-6, and sap9-10)
and examined their capacity to modulate cytokine production
(Fig. 4A). The results showed that the conditioned medium
from different sap mutants induced cytokine modulation ef-
fects similar to those of wild-type C. albicans, demonstrating
that neither Sap1-3, Sap4-6, nor Sap1-10 is necessary for the
modulation of cytokine production.
To further dissect the factors responsible for this effect, we
collected the conditioned medium and divided it into different
fractions according the molecular mass (small, 3 to 
30 kDa;
intermediate, 30 to 
100 kDa; large, 100 kDa) and tested
their abilities to modulate heat-killed C. albicans-induced cy-
tokine production (Fig. 4B). We found that the small fraction
contains the active components, because it can induce a cyto-
FIG. 3. Cross talk between TLRs and PARs. Human PBMCs were treated with LPS (A), Pam3Cys (B), and -glucan (C) in a dose-dependent
manner, in combination with RPMI medium, PAR1 agonist (PAR1-AP) (TFLLR), or PAR2-AP (SLIGRL), respectively. Supernatants were
collected for TNF, IL-6, and IL-8 measurements after 24 h of stimulation. The data are cumulative results of three duplicate data from 6 different
donors and are expressed as means  SE (*, P 	 0.05 compared to PBMCs stimulated with LPS alone).
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kine modulation effect similar to that of the complete condi-
tioned medium. Also, the large fraction can potentiate IL-8
production and, to a lesser extent, IL-6 production. However,
no modulation effect was observed in the intermediate frac-
tion, where all the Saps are located, as the molecular mass of
Saps is between 34 and 45 kDa.
DISCUSSION
Through the recognition of PAMPs on the C. albicans sur-
face, innate cells can eliminate fungi directly by phagocytosis
or can activate host defense mechanisms by secreting different
chemokines and cytokines. Much has been learned about the
PRRs responsible for the recognition of C. albicans cell wall
components such as mannan and -glucans. However, C. albi-
cans also releases soluble factors during infections, some of
them with enzymatic properties, such as secreted aspartic pro-
teases (Saps) (12). It was recently proposed that the activation
of PAR1 and PAR2 by C. albicans-released proteases contrib-
utes to the activation of cytokine production and, in coordina-
tion with TLR signaling, is important for antifungal immunity
in mice. However, nothing is known regarding the role of PAR1
and PAR2 receptors in antifungal immunity in humans. In the
present study, we investigated the role of human PAR1 and
PAR2 in C. albicans recognition and the activation of proin-
flammatory cytokines. We show that soluble factors released
by live C. albicans cells potentiate IL-6 and IL-8 production
induced by heat-killed C. albicans cells, but this effect is ex-
erted mostly in a PAR-independent manner.
Regarding the cytokine profile induce by C. albicans in vitro,
most previously reported studies were performed with heat-
killed C. albicans cells. Two main reasons were responsible for
this. First, heat-killed C. albicans cells are more immunogenic
than live C. albicans cells, and this is due to the exposure of the
PAMPs on the surface after heat killing. For example, -glu-
can is usually masked by the outer mannoprotein layer (5) and
exposed only on the budding scar (4). However, -glucan will
be exposed after heat exposure (5, 22). Second, heat-killed C.
albicans cells are easier to handle, while live C. albicans cells
can outgrow and kill the host cells that they are supposed to
stimulate. However, there are also drawbacks of using heat-
killed C. albicans. Not only is the PAMP distribution changed
and different from that of live C. albicans cells, but the involve-
ment of the soluble factors secreted by live C. albicans, which
might actively shape the host immune response, is also over-
looked.
To investigate the possible modulating effect elicited by fac-
tors released by live C. albicans cells, conditioned medium
from C. albicans cultures was used to stimulate human PBMCs.
However, conditioned medium alone could not induce TNF
and IL-6 secretion yet slightly induced IL-8 secretion. It ap-
peared, therefore, that the secreted soluble factors by them-
selves possess no stimulating ability to induce host cytokine
production. We have further tested whether the conditioned
medium can modulate the cytokine profile induced by heat-
killed C. albicans cells. The production of IL-6 and IL-8 in-
duced by heat-killed C. albicans cells was potentiated by con-
ditioned medium. The same cytokine modulation pattern was
observed when a transwell system containing both live and
FIG. 4. Saps are not responsible for the cytokine modulation effect. (A) Human PBMCs were stimulated with heat-killed C. albicans cells in
the presence of RPMI or conditioned medium from wild-type (WT) C. albicans or from C. albicans strains defective in different Saps: sap1-3,
sap4-6, or sap9-10. Supernatants were collected for IL-6 and IL-8 measurements after 24 h of stimulation. (B) Human PBMCs were stimulated
with heat-killed C. albicans cells in the presence of different fractions of C. albicans conditioned medium. Supernatant collected for IL-6 and IL-8
measurements after 24 h shows the relative cytokine percentages induced by conditioned medium above control stimulation with heat-killed C.
albicans cells alone.
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heat-killed fungi was used. These data demonstrate that live C.
albicans cells can release soluble factors that modulate the host
response induced by cell wall components. In addition, apart
from proinflammatory cytokines such as IL-6 and IL-8, we
found that the Th1/Th2 signature cytokines were also altered
by the conditioned medium (our unpublished data), suggesting
an active role of C. albicans in modulating the host immune
response during infection.
A second aim of our studies was to assess the possible in-
volvement of PARs in the modulatory effect of C. albicans-
released mediators. Previous studies demonstrated the activa-
tion of cytokine release by bacterial proteases that activate
PARs (21), and a role for PAR1 and PAR2 in the anti-C.
albicans defense in mice was previously suggested (11). Our
results indicate that PAR1/2 ligation has a slight stimulatory
effect on TLR4 signaling, leading to augmented IL-8 produc-
tion, which is in line with data reported previously by Rallab-
handi et al. (16). However, PAR1 and PAR2 agonists failed to
potentiate IL-6 or IL-8 production induced by PBMCs stimu-
lated with heat-killed C. albicans cells despite a marginal effect
on IL-6 production when PAR1 and PAR2 agonists were used
in combination.
There are two possibilities to explain these results. On the
one hand, PAR1 and PAR2 are not involved in C. albicans-
induced cytokine production, so the addition of a PAR agonist
has no effect on cytokine production. On the other hand, the
modulatory effect of C. albicans might be due to the induction
of host proteases, which by themselves activate PARs, and the
addition of a PAR agonist has no additional effect because
PARs are already activated. Therefore, PAR antagonists were
applied in the transwell system to block PAR signaling to
differentiate between these two different possibilities. In this
way, either C. albicans PAR or host PAR signaling would be
blocked. However, both PAR1 and PAR2 antagonists failed to
reverse the upregulated IL-6 and IL-8 production induced by
live C. albicans cells. This suggests that the soluble factors
released by C. albicans modulate the human immune response
largely through a PAR-independent pathway. From this point
of view, it seems that human and murine PARs function dif-
ferently in C. albicans infection, at least in the case of the
response of PBMCs toward C. albicans. Based on the results
that we have found, we suggest that human PAR1 and PAR2
are not as important in mice for the modulation of host im-
munity against C. albicans infection or at least that the role of
PAR1/PAR2 is redundant because other pathways (e.g., TLRs
and CLRs) are capable of fully compensating for their absence.
The discrepancy between the results described previously by
Moretti et al. (11) and ours might be due to the different C.
albicans strains used. To investigate whether this accounted for
the discrepancy, we applied another clinically isolated C. albi-
cans strain and other Candida species like C. glabrata and C.
dubliniensis. However, the two different C. albicans strains and
other Candida spp. showed a similar cytokine modulation phe-
nomenon (data not shown). Therefore, this effect is not Can-
dida strain specific but more likely a general modulation func-
tion of all Candida spp. Notwithstanding, we cannot rule out
the possibility of the involvement of PAR1/2 in other experi-
mental models such as mucosal infection, where other cell
types are involved in the pathological process.
Another line of evidence is the role of Saps. Since Saps were
reported to be important virulence factors for C. albicans in-
fection, it is reasonable to hypothesize a link between Saps and
the immunomodulation effect induced by live C. albicans cells.
In our experiment we compared the conditioned media of
wild-type C. albicans and other sap mutants. However, there
was no significant difference among the wild type and sap
mutants irrespective of the different Sap compositions in the
conditioned medium. We also found that the major modula-
tory components are within the small fraction (3 to 
30 kDa)
and, to a lesser extent, the large fraction (100 kDa). This
result is in line with the results from sap mutants, because the
molecular mass of Saps is between 34 and 45 kDa, which falls
within the range of the intermediate fraction (30 to 
100 kDa),
suggesting that Saps are less likely to play a role in the mod-
ulation of host cytokine production. Nevertheless, other po-
tential components released by C. albicans, such as glycans,
lipases, phospholipases, or metabolites, might be involved in
the modulation of the immune response. It was previously
shown that certain chemotactic factors produced by C. albicans
could induce the chemotaxis of PMNs and macrophages by
binding to formyl peptide receptor (FPR) (3). This further
demonstrates that the soluble factors secreted/produced by live
C. albicans cells can be sensed by or modulate the host immune
system in an active manner. Therefore, further identification of
the factors responsible for this cytokine modulation effect de-
serves further investigation.
In conclusion, we demonstrate that live C. albicans cells can
actively modulate the host immune response in the presence of
fungal PAMPs by releasing soluble factors. However, in con-
trast to murine cells, human PAR1 and PAR2 do not play a
major role in the stimulation of cytokine production by C.
albicans. These data add to our understanding of the mecha-
nism of host defense activation by fungi and open a new ave-
nue of research in the field of immune activation by soluble
components of pathogenic microorganisms.
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